Clinical Trial Update: A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating chemoradiotherapy with gemcitabine and nab-paclitaxel for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)

Snippet

Sponsor: Osaka Medical Center for Cancer and Cardiovascular Diseases | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED